Editor: NOEL GONZÁLEZ GOTERA Número 121 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 010214– 070214 Fotos: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.
ARTÍCULOS CIENTÍFICOS
Publicaciones incluidas en PubMED durante el período comprendido entre el 1 y el 7 de febrero de 2014. Con “vaccin*” en título: 162 artículos recuperados.
Vacunas Meningococo (Neisseriia meningitidis)
83. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens.
Williams JN, Weynants V, Poolman JT, Heckels JE, Christodoulides M.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00085-1. doi: 10.1016/j.vaccine.2013.12.070. [Epub ahead of print]
PMID: 24486354 [PubMed - as supplied by publisher]
Related citations
Select item 24486352
138. Neisseria meningitidis B vaccines: recent advances and possible immunization policies.
Gasparini R, Amicizia D, Domnich A, Lai PL, Panatto D.
Expert Rev Vaccines. 2014 Jan 29. [Epub ahead of print]
PMID: 24476428 [PubMed - as supplied by publisher]
Related citations
Select item 24476349
1
Vacunas BCG – ONCO BCG (Mycobacterium bovis)
80. Comparison of antibody and cell-mediated immune responses of foals and adult horses after vaccination with live Mycobacterium bovis BCG.
Sturgill TL, Giguère S, Berghaus LJ, Hurley DJ, Hondalus MK.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00064-4. doi: 10.1016/j.vaccine.2014.01.032. [Epub ahead of print]
PMID: 24486362 [PubMed - as supplied by publisher]
Related citations
Select item 24486360
124. Inadvertent Intramuscular Administration of High Dose Bacillus Calmette Guerin Vaccine in a Pre-term Infant.
Banu A, Loganathan E.
J Family Med Prim Care. 2013 Jan;2(1):95-7. doi: 10.4103/2249-4863.109967.
PMID: 24479056 [PubMed] Free PMC Article
Related citations
Select item 24478808
Vacunas Neumococo (Streptococcus pneumoniae)
25. A cross-sectional study to investigate pneumococcal vaccination in the elderly in a low income county: Patient knowledge, awareness, and attitudes of vaccination and prevalence rates by socioeconomic status.
Baig SA, Hassan M, Ahmed SM, Moazzam W, Inayat A.
Hum Vaccin Immunother. 2014 Feb 4;10(4). [Epub ahead of print]
PMID: 24495898 [PubMed - as supplied by publisher]
Related citations
Select item 24495208
74. Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack- Matched case control study.
Siriwardena AN, Asghar Z, Coupland CA.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00061-9. doi: 10.1016/j.vaccine.2014.01.029. [Epub ahead of print]
PMID: 2
24486370 [PubMed - as supplied by publisher]
Related citations
Select item 24486369
78. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR.
Pasinato A, Indolfi G, Marchisio P, Valleriani C, Cortimiglia M, Spanevello V, Chiamenti G, Buzzetti R, Resti M, Azzari C; The Italian Group for the Study of Bacterial Nasopharyngeal Carriage in Children.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00055-3. doi: 10.1016/j.vaccine.2014.01.023. [Epub ahead of print]
PMID: 24486364 [PubMed - as supplied by publisher]
Related citations
Select item 24486363
87. Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.
Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00080-2. doi: 10.1016/j.vaccine.2013.11.106. [Epub ahead of print]
PMID: 24486348 [PubMed - as supplied by publisher]
Related citations
Select item 24486347
89. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.
De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, Landry M.
Vaccine. 2014 Jan 30. pii: S0264-410X(13)01545-4. doi: 10.1016/j.vaccine.2013.11.028. [Epub ahead of print]
PMID: 24486346 [PubMed - as supplied by publisher]
Related citations
Select item 24486345
3
Vacuna Tosferina (Bordetella pertussis)
99. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH, Ross PJ, Allen AC, Wilk MM.
Trends Microbiol. 2014 Feb;22(2):49-52. doi: 10.1016/j.tim.2013.11.007.
PMID: 24485284 [PubMed - in process]
Related citations
Select item 24485154
109. Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older.
Menzies RI, Jayasinghe SH, Krause VL, Chiu CK, McIntyre PB.
Med J Aust. 2014 Feb 3;200(2):112-5.
PMID: 24484116 [PubMed - in process]
Related citations
Select item 24484101
115. Identification of Potential Vaccine Candidates Against Streptococcus pneumoniae by Reverse Vaccinology Approach.
Talukdar S, Zutshi S, Prashanth KS, Saikia KK, Kumar P.
Appl Biochem Biotechnol. 2014 Jan 31. [Epub ahead of print]
PMID: 24482282 [PubMed - as supplied by publisher]
Related citations
Select item 24482005
Vacuna Tuberculosis (Mycobacterium tuberculosis)
9. The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses.
Tameris M, Geldenhuys H, Luabeya AK, Smit E, Hughes JE, Vermaak S, Hanekom WA, Hatherill M, Mahomed H, McShane H, Scriba TJ.
PLoS One. 2014 Feb 3;9(2):e87340. doi: 10.1371/journal.pone.0087340. eCollection 2014.
PMID: 24498312 [PubMed - in process]
Related citations
4
Select item 24498149
27. Challenges and solutions for a rational vaccine design for TB-endemic regions.
Gowthaman U, Mushtaq K, Tan AC, Rai PK, Jackson DC, Agrewala JN.
Crit Rev Microbiol. 2014 Feb 4. [Epub ahead of print]
PMID: 24495096 [PubMed - as supplied by publisher]
Related citations
Select item 24494957
Vacunas cóleras (Vibrio cholerae)
162. The utility of human challenge studies in vaccine development: lessons learned from cholera.
Shirley DA, McArthur MA.
Vaccine (Auckl). 2011 Oct;2011(1):3-13.
PMID: 24482781 [PubMed] Free PMC Article
Related citations
Vacunas, otras
1. Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas.
Sheng Sow H, Mattarollo SR.
Oncoimmunology. 2013 Dec 1;2(12):e27058. Epub 2013 Nov 5. Review.
PMID: 24498564 [PubMed]
Related citations
Select item 24498563 2.
Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L.
Llopiz D, Huarte E, Ruiz M, Bezunartea J, Belsúe V, Zabaleta A, Lasarte JJ, Prieto J, Borrás-Cuesta F, Sarobe P.
Oncoimmunology. 2013 Dec 1;2(12):e27009. Epub 2013 Dec 5.
5
PMID: 24498563 [PubMed]
Related citations
Select item 24498551 3.
Vaccine therapy for pancreatic cancer.
Salman B, Zhou D, Jaffee EM, Edil BH, Zheng L.
Oncoimmunology. 2013 Dec 1;2(12):e26662. Epub 2013 Oct 22. Review.
PMID: 24498551 [PubMed]
Related citations
Select item 24498550 4.
Trial Watch: Peptide vaccines in cancer therapy.
Aranda F, Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.
Oncoimmunology. 2013 Dec 1;2(12):e26621. Epub 2013 Nov 4. Review.
PMID: 24498550 [PubMed]
Related citations
Select item 24498547 5.
Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients.
Okuyama R, Aruga A, Hatori T, Takeda K, Yamamoto M.
Oncoimmunology. 2013 Nov 1;2(11):e27010. Epub 2013 Nov 5.
PMID: 24498547 [PubMed]
Related citations
6
Select item 24498495 6.
Evaluation of vaccine cold chain in urban health centers of municipal corporation of surat city, Western India.
Naik AK, Rupani MP, Bansal RK.
Int J Prev Med. 2013 Dec;4(12):1395-401.
PMID: 24498495 [PubMed]
Related citations
Select item 24498468 7.
Overexpression of recombinant HIV-1 Subtype C Tat and Nef in a Salmonella vaccine vector.
Chin'ombe N, Lebeko M, Kgatle M.
Pan Afr Med J. 2013 Sep 17;16:19. doi: 10.11604/pamj.2013.16.19.2759. eCollection 2013.
PMID: 24498468 [PubMed - in process]
Related citations
Select item 24498433 8.
Recombinant plants provide a new approach to the production of bacterial polysaccharide for vaccines.
Smith CM, Fry SC, Gough KC, Patel AJ, Glenn S, Goldrick M, Roberts IS, Whitelam GC, Andrew PW.
PLoS One. 2014 Feb 3;9(2):e88144. doi: 10.1371/journal.pone.0088144. eCollection 2014.
PMID: 24498433 [PubMed - in process]
Related citations
Select item 24498312 9.
7
The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses.
Tameris M, Geldenhuys H, Luabeya AK, Smit E, Hughes JE, Vermaak S, Hanekom WA, Hatherill M, Mahomed H, McShane H, Scriba TJ.
PLoS One. 2014 Feb 3;9(2):e87340. doi: 10.1371/journal.pone.0087340. eCollection 2014.
PMID: 24498312 [PubMed - in process]
Related citations
Select item 24498149 10.
Management of Hepatitis E Virus (HEV) Zoonotic Transmission: Protection of Rabbits against HEV Challenge following Immunization with HEV 239 Vaccine.
Liu P, Du RJ, Wang L, Han J, Liu L, Zhang YL, Xia JK, Lu FM, Zhuang H.
PLoS One. 2014 Jan 30;9(1):e87600. doi: 10.1371/journal.pone.0087600. eCollection 2014 Jan 3.
PMID: 24498149 [PubMed - in process]
Related citations
Select item 24498145 11.
Cost-Effectiveness of Alternative Strategies for Annual Influenza Vaccination among Children Aged 6 Months to 14 Years in Four Provinces in China.
Zhou L, Situ S, Feng Z, Atkins CY, Fung IC, Xu Z, Huang T, Hu S, Wang X, Meltzer MI.
PLoS One. 2014 Jan 31;9(1):e87590. doi: 10.1371/journal.pone.0087590. eCollection 2014.
PMID: 24498145 [PubMed - in process]
Related citations
Select item 24497955 12.
PAMAM-Lys, a Novel Vaccine Delivery Vector, Enhances the Protective Effects of the SjC23 DNA Vaccine against Schistosoma japonicum Infection.
8
Wang X, Dai Y, Zhao S, Tang J, Li H, Xing Y, Qu G, Li X, Dai J, Zhu Y, Zhang X.
PLoS One. 2014 Jan 30;9(1):e86578. doi: 10.1371/journal.pone.0086578. eCollection 2014 Jan 3.
PMID: 24497955 [PubMed - in process]
Related citations
Select item 24497934 13.
Block Copolymer/DNA Vaccination Induces a Strong Allergen-Specific Local Response in a Mouse Model of House Dust Mite Asthma.
Rolland-Debord C, Lair D, Roussey-Bihouée T, Hassoun D, Evrard J, Cheminant MA, Chesné J, Braza F, Mahay G, Portero V, Sagan C, Pitard B, Magnan A.
PLoS One. 2014 Jan 31;9(1):e85976. doi: 10.1371/journal.pone.0085976. eCollection 2014.
PMID: 24497934 [PubMed - in process]
Related citations
Select item 24497878 14.
Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran.
Norouzirad R, Shakurnia AH, Assarehzadegan MA, Serajian A, Khabazkhoob M.
Hepat Mon. 2014 Jan 12;14(1):e13625. doi: 10.5812/hepatmon.13625. eCollection 2014 Jan.
PMID: 24497878 [PubMed]
Related citations
Select item 24497461 15.
Sample size determination for the weighted log-rank test with the Fleming-Harrington class of weights in cancer vaccine studies.
Hasegawa T.
9
Pharm Stat. 2014 Feb 5. doi: 10.1002/pst.1609. [Epub ahead of print]
PMID: 24497461 [PubMed - as supplied by publisher]
Related citations
Select item 24497203 16.
Incomplete Hepatitis B Immunization, Maternal Carrier Status and Increased Risk of Liver Diseases: A 20-year Cohort Study of 3.8 Million Vaccinees.
Chien YC, Jan CF, Chiang CJ, Kuo HS, You SL, Chen CJ.
Hepatology. 2014 Feb 4. doi: 10.1002/hep.27048. [Epub ahead of print]
PMID: 24497203 [PubMed - as supplied by publisher]
Related citations
Select item 24497128 17.
Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM.
Pharmacoepidemiol Drug Saf. 2014 Feb 4. doi: 10.1002/pds.3575. [Epub ahead of print]
PMID: 24497128 [PubMed - as supplied by publisher]
Related citations
Select item 24496826 18.
Protection from Lethal Challenge in a Neonatal Mouse Model by Circulating Recombinant Form Coxsackievirus A16 Vaccine Candidates.
Li J, Chang J, Liu X, Yang J, Guo H, Wei W, Zhang W, Yu XF.
J Gen Virol. 2014 Feb 4. doi: 10.1099/vir.0.063560-0. [Epub ahead of print]
PMID: 24496826
10
[PubMed - as supplied by publisher]
Related citations
Select item 24496777 19.
Perceptions des communautes sur le paludisme et les vaccins : etude qualitative realisee dans les districts sanitaires de Kaya et Hounde, au Burkina Faso.
Yaya Bocoum FI, Kouanda S, Hinson L, Collymore Y, Ba-Nguz A, Bingham A.
Glob Health Promot. 2014 Feb 4. [Epub ahead of print]
PMID: 24496777 [PubMed - as supplied by publisher]
Related citations
Select item 24496526 20.
Hormones may affect influenza vaccine response.
Hampton T.
JAMA. 2014 Feb 5;311(5):456. doi: 10.1001/jama.2014.287. No abstract available.
PMID: 24496526 [PubMed - in process]
Related citations
Select item 24496468 21.
"Vaccine hesitant" parents affect vaccination rates in some communities.
Jacob JA.
BMJ. 2014 Feb 4;348:g1211. doi: 10.1136/bmj.g1211. No abstract available.
PMID: 24496468 [PubMed - in process]
Related citations
Select item 24496208 22.
11
Bacterial meningitis in Malawian adults, adolescents and children during the era of antiretroviral scale-up and Hib vaccination (2000-2012).
Wall EC, Everett DB, Mukaka M, Bar-Zeev N, Feasey N, Jahn A, Moore M, van Oosterhout JJ, Pensalo P, Baguimira K, Gordon SB, Molyneux EM, Carrol ED, French N, Molyneux ME, Heyderman RS.
Clin Infect Dis. 2014 Feb 4. [Epub ahead of print]
PMID: 24496208 [PubMed - as supplied by publisher]
Related citations
Select item 24496054 23.
Commercializing diarrhea vaccines for travelers.
López-Gigosos R, Segura-Moreno M, Díez-Díaz R, Plaza E, Mariscal A.
Hum Vaccin Immunother. 2014 Feb 4;10(6). [Epub ahead of print] Review.
PMID: 24496054 [PubMed - as supplied by publisher]
Related citations
Select item 24495909 24.
Differences in Antibody Responses between TIV and LAIV Influenza Vaccines Correlate with the Kinetics and Magnitude of Interferon Signaling in Children.
Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García- Sastre A, Mejias A, Xu H, Qin H, Blankenship D, Palucka K, Pascual V, Ramilo O.
J Infect Dis. 2014 Feb 4. [Epub ahead of print]
PMID: 24495909 [PubMed - as supplied by publisher]
Related citations
Select item 24495898 25.
A cross-sectional study to investigate pneumococcal vaccination in the elderly in a low income county: Patient knowledge, awareness, and attitudes of vaccination and prevalence rates by socioeconomic status.
12
Baig SA, Hassan M, Ahmed SM, Moazzam W, Inayat A.
Hum Vaccin Immunother. 2014 Feb 4;10(4). [Epub ahead of print]
PMID: 24495898 [PubMed - as supplied by publisher]
Related citations
Select item 24495208 26.
Signatures of malaria vaccine efficacy in aging murine immune memory.
Haussig JM, Burgold J, Hafalla JC, Matuschewski K, Kooij TW.
Parasite Immunol. 2014 Feb 4. doi: 10.1111/pim.12104. [Epub ahead of print]
PMID: 24495208 [PubMed - as supplied by publisher]
Related citations
Select item 24495096 27.
Challenges and solutions for a rational vaccine design for TB-endemic regions.
Gowthaman U, Mushtaq K, Tan AC, Rai PK, Jackson DC, Agrewala JN.
Crit Rev Microbiol. 2014 Feb 4. [Epub ahead of print]
PMID: 24495096 [PubMed - as supplied by publisher]
Related citations
Select item 24494957 28.
Barriers to better three-dose coverage with HPV vaccination in school-based programs.
Watson M, Lynch J, D'Onise K, Brotherton J.
Aust N Z J Public Health. 2014 Feb;38(1):91-2. doi: 10.1111/1753-6405.12149. No abstract available.
PMID: 24494957 [PubMed - in process]
13
Related citations
Select item 24494952 29.
Are they protected? Immunity to vaccine-preventable diseases in healthcare workers at an Australian hospital.
Leung V, Harper S, Slavin M, Thursky K, Worth L.
Aust N Z J Public Health. 2014 Feb;38(1):83-6. doi: 10.1111/1753-6405.12163.
PMID: 24494952 [PubMed - in process]
Related citations
Select item 24494813 30.
The Swedish polio vaccine in memoriam.
Lycke E.
Acta Paediatr. 2014 Feb 3. doi: 10.1111/apa.12584. [Epub ahead of print]
PMID: 24494813 [PubMed - as supplied by publisher]
Related citations
Select item 24494812 31.
Advances in enteric disease vaccines: from innovation to implementation.
Parker EP.
Expert Rev Vaccines. 2014 Feb 5. [Epub ahead of print]
PMID: 24494812 [PubMed - as supplied by publisher]
Related citations
Select item 24494784 32.
Varicella vaccination: a laboured take-off.
Carrillo-Santisteve P, Lopalco PL. 14
Clin Microbiol Infect. 2014 Feb 3. doi: 10.1111/1469-0691.12580. [Epub ahead of print]
PMID: 24494784 [PubMed - as supplied by publisher]
Related citations
Select item 24494363 33.
2009 H1N1 vaccination in Minnesota: an evaluation by ZIP code.
Muscoplat MH, Roddy M, Parilla E, Davey CS, Fleege L, White K, Ehresmann K.
Minn Med. 2013 Sep;96(9):49-54.
PMID: 24494363 [PubMed - in process]
Related citations
Select item 24493925 34.
Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs.
Binjawadagi B, Dwivedi V, Manickam C, Ouyang K, Wu Y, Lee LJ, Torrelles JB, Renukaradhya GJ.
Int J Nanomedicine. 2014 Jan 24;9:679-94. doi: 10.2147/IJN.S56127. eCollection 2014.
PMID: 24493925 [PubMed - in process] Free Article
Related citations
Select item 24492697 35.
Glossopharyngeal nerve and vagus nerve palsies associated with influenza vaccination.
Ishii K, Kanazawa T, Tomidokoro Y, Tamaoka A.
Intern Med. 2014;53(3):259-61.
15
PMID: 24492697 [PubMed - in process] Free Article
Related citations
Select item 24492621 36.
Long-term single-dose efficacy of a vesicular stomatitis virus-based andes virus vaccine in Syrian hamsters.
Prescott J, Debuysscher BL, Brown KS, Feldmann H.
Viruses. 2014 Jan 31;6(2):516-23. doi: 10.3390/v6020516.
PMID: 24492621 [PubMed - in process] Free Article
Related citations
Select item 24492538 37.
Workplace-Based Influenza Vaccination Promotion Practices Among Large Employers in the United States.
Graves MA, Harris JR, Hannon PA, Hammerback K, Ahmed F, Zhou C.
J Occup Environ Med. 2014 Jan 31. [Epub ahead of print]
PMID: 24492538 [PubMed - as supplied by publisher]
Related citations
Select item 24492530 38.
Current and potential immune therapies and vaccines in the management of psoriasis.
Kaffenberger BH, Lee GL, Tyler K, Chan DV, Jarjour W, Ariza ME, Williams MV, Wong HK.
Hum Vaccin Immunother. 2014 Feb 3;10(4). [Epub ahead of print] Review.
PMID: 24492530 [PubMed - as supplied by publisher]
16
Related citations
Select item 24492526 39.
Peripartum outcomes: non-adjuvanted v. adjuvanted H1N1 vaccination.
Ray JG, McGeer AJ, Blake JM, Lebovic G, Smith GN, Yudin MH.
CMAJ. 2014 Feb 4;186(2):137. doi: 10.1503/cmaj.114-0006. No abstract available.
PMID: 24492526 [PubMed - in process]
Related citations
Select item 24492286 40.
Changes in Hospitalizations for Pneumonia after Universal Vaccination with Pneumococcal Conjugate Vaccines 7/13 Valent and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric Referral Hospital in Uruguay.
Pírez MC, Algorta G, Chamorro F, Romero C, Varela A, Cedres A, Giachetto G, Montano A.
Pediatr Infect Dis J. 2014 Jan 31. [Epub ahead of print]
PMID: 24492286 [PubMed - as supplied by publisher]
Related citations
Select item 24492016 41.
Refusal of oral polio vaccine in northwestern Pakistan: A qualitative and quantitative study.
Murakami H, Kobayashi M, Hachiya M, Khan ZS, Hassan SQ, Sakurada S.
Vaccine. 2014 Jan 31. pii: S0264-410X(14)00050-4. doi: 10.1016/j.vaccine.2014.01.018. [Epub ahead of print]
PMID: 24492016 [PubMed - as supplied by publisher]
Related citations
Select item 24492015 42.
17
School-based vaccination of young US males: Impact of health beliefs on intent and first dose acceptance.
Rickert VI, Auslander BA, Cox DS, Rosenthal SL, Rickert JA, Rupp R, Zimet GD.
Vaccine. 2014 Jan 31. pii: S0264-410X(14)00088-7. doi: 10.1016/j.vaccine.2014.01.049. [Epub ahead of print]
PMID: 24492015 [PubMed - as supplied by publisher]
Related citations
Select item 24492014 43.
Carrier priming or suppression: Understanding carrier priming enhancement of anti- polysaccharide antibody response to conjugate vaccines.
Pobre K, Tashani M, Ridda I, Rashid H, Wong M, Booy R.
Vaccine. 2014 Jan 31. pii: S0264-410X(14)00084-X. doi: 10.1016/j.vaccine.2014.01.047. [Epub ahead of print] Review.
PMID: 24492014 [PubMed - as supplied by publisher]
Related citations
Select item 24492013 44.
DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.
Smith HA, Rekoske BT, McNeel DG.
Vaccine. 2014 Jan 31. pii: S0264-410X(14)00086-3. doi: 10.1016/j.vaccine.2014.01.048. [Epub ahead of print]
PMID: 24492013 [PubMed - as supplied by publisher]
Related citations
Select item 24491922 45.
Avian influenza vaccines against H5N1 'bird flu'
Li C, Bu Z, Chen H.
18
Trends Biotechnol. 2014 Jan 31. pii: S0167-7799(14)00002-X. doi: 10.1016/j.tibtech.2014.01.001. [Epub ahead of print] Review.
PMID: 24491922 [PubMed - as supplied by publisher]
Related citations
Select item 24491528 46.
An allergen-polymeric nanoaggregate as a new tool for allergy vaccination.
Mariano L, Giovanna M, Luisa BM, Angela B, Cinzia S, Mario M, Calogero F, Gaetano G, Paolo C.
Int J Pharm. 2014 Jan 31. pii: S0378-5173(14)00052-0. doi: 10.1016/j.ijpharm.2014.01.031. [Epub ahead of print]
PMID: 24491528 [PubMed - as supplied by publisher]
Related citations
Select item 24491412 47.
HPV Vaccine Use among African American Girls: Qualitative Formative Research using a Participatory Social Marketing Approach.
Hull PC, Williams EA, Khabele D, Dean C, Bond B, Sanderson M.
Gynecol Oncol. 2014 Jan 31. pii: S0090-8258(14)00106-1. doi: 10.1016/j.ygyno.2014.01.046. [Epub ahead of print]
PMID: 24491412 [PubMed - as supplied by publisher]
Related citations
Select item 24491087 48.
Influenza vaccination in immunocompromised patients: efficacy and safety.
Zbinden D, Manuel O.
Immunotherapy. 2014 Feb;6(2):131-9. doi: 10.2217/imt.13.171.
PMID: 24491087
19
[PubMed - in process]
Related citations
Select item 24491084 49.
Vaccines against neglected tropical diseases: promising interventions to rescue the poorest populations in the Americas.
Bottazzi ME.
Immunotherapy. 2014 Feb;6(2):117-9. doi: 10.2217/imt.13.159. No abstract available.
PMID: 24491084 [PubMed - in process]
Related citations
Select item 24491047 50.
[Construction and identification of H5 subtype avian influenza vaccine candidate based on flagellin].
Wang J, Kang X, Jiao Y, Xiong D, Song L, Yang Y, Pan Z, Jiao X.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Feb;30(2):117-20. Chinese.
PMID: 24491047 [PubMed - in process]
Related citations
Select item 24491046 51.
[Therapeutic effect and mechanism of Phoenix roebelenii pollen vaccine for treatment of mice with allergic rhinitis].
Jiang C, Xiao X, Ma L, Zhang X, Liu Z.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Feb;30(2):113-6. Chinese.
PMID: 24491046 [PubMed - in process]
Related citations
20
Select item 24490714 52.
Influenza vaccination coverage in children with inflammatory bowel disease.
Banaszkiewicz A, Klincewicz B, Lazowska-Przeorek I, Grzybowska-Chlebowczyk U, Kąkol P, Mytyk A, Kofla A, Radzikowski A.
Influenza Other Respir Viruses. 2014 Feb 3. doi: 10.1111/irv.12236. [Epub ahead of print]
PMID: 24490714 [PubMed - as supplied by publisher]
Related citations
Select item 24490684 53.
Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥50 years.
Dawood FS, Prapasiri P, Areerat P, Ruayajin A, Chittaganpitch M, Muangchana C, Baggett HC, Olsen SJ.
Influenza Other Respir Viruses. 2014 Feb 3. doi: 10.1111/irv.12233. [Epub ahead of print]
PMID: 24490684 [PubMed - as supplied by publisher]
Related citations
Select item 24490585 54.
Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.
Hanke T.
Expert Opin Biol Ther. 2014 Feb 3. [Epub ahead of print]
PMID: 24490585 [PubMed - as supplied by publisher]
Related citations
Select item 24490154 55.
21
Construction and Immunogenicity of DNA Vaccines Encoding Fusion Protein of Porcine IFN- λ 1 and GP5 Gene of Porcine Reproductive and Respiratory Syndrome Virus.
Du L, Li B, He K, Zhang H, Huang K, Xiao S.
Biomed Res Int. 2013;2013:318698. doi: 10.1155/2013/318698. Epub 2013 Dec 24.
PMID: 24490154 [PubMed - in process] Free PMC Article
Related citations
Select item 24489912 56.
A Low Gastric pH Mouse Model to Evaluate Live Attenuated Bacterial Vaccines.
Brenneman KE, Willingham C, Kilbourne JA, 3rd RC, Roland KL.
PLoS One. 2014 Jan 29;9(1):e87411. eCollection 2014.
PMID: 24489912 [PubMed - as supplied by publisher] Free PMC Article
Related citations
Select item 24489871 57.
A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila.
Cowan GJ, Bockau U, Eleni-Muus J, Aldag I, Samuel K, Creasey AM, Hartmann MW, Cavanagh DR.
PLoS One. 2014 Jan 29;9(1):e87198. doi: 10.1371/journal.pone.0087198. eCollection 2014.
PMID: 24489871 [PubMed - in process] Free PMC Article
Related citations
Select item 24489846 58.
ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo.
22
Norton JE Jr, Lytle AG, Shen S, Tzvetkov EP, Dorfmeier CL, McGettigan JP.
PLoS One. 2014 Jan 29;9(1):e87098. doi: 10.1371/journal.pone.0087098. eCollection 2014.
PMID: 24489846 [PubMed - in process] Free PMC Article
Related citations
Select item 24489827 59.
Dietary Enterococcus faecium NCIMB 10415 and Zinc Oxide Stimulate Immune Reactions to Trivalent Influenza Vaccination in Pigs but Do Not Affect Virological Response upon Challenge Infection.
Wang Z, Burwinkel M, Chai W, Lange E, Blohm U, Breithaupt A, Hoffmann B, Twardziok S, Rieger J, Janczyk P, Pieper R, Osterrieder N.
PLoS One. 2014 Jan 28;9(1):e87007. doi: 10.1371/journal.pone.0087007. eCollection 2014.
PMID: 24489827 [PubMed - in process] Free PMC Article
Related citations
Select item 24489558 60.
Respiratory infection and otitis media visits in relation to pneumococcal conjugate vaccine use in Saskatchewan.
Khuc NH, Tan B, Tuchscherer R, Rawson NS, De Wals P.
Can J Infect Dis Med Microbiol. 2013 Winter;24(4):179-84.
PMID: 24489558 [PubMed]
Related citations
Select item 24489557 61.
New vaccines - which ones should we choose?
Robinson J.
23
Can J Infect Dis Med Microbiol. 2013 Winter;24(4):177-8. No abstract available.
PMID: 24489557 [PubMed]
Related citations
Select item 24489346 62.
A8.38 MMF treatment differentially regulates immune responses to vaccination by PNEUMOVAX but not prevnar in MRL/LPR mice.
Gazivoda V, Mehta S, Wang L, Sperber K, Tassiulas I.
Ann Rheum Dis. 2014 Mar 1;73 Suppl 1:A91-2. doi: 10.1136/annrheumdis-2013- 205124.212.
PMID: 24489346 [PubMed - in process]
Related citations
Select item 24488747 63.
Risk Perceptions and Subsequent Sexual Behaviors After HPV Vaccination in Adolescents.
Mayhew A, Mullins TL, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA.
Pediatrics. 2014 Feb 2. [Epub ahead of print]
PMID: 24488747 [PubMed - as supplied by publisher]
Related citations
Select item 24488402 64.
Vaccination against human papillomavirus.
Mello CF.
Einstein (Sao Paulo). 2013 Dec;11(4):547-549. English, Portuguese.
PMID: 24488402 [PubMed - as supplied by publisher] Free Article
24
Related citations
Select item 24488301 65.
Chen et al. Cost-effectiveness of Augmenting Universal Hepatitis B Vaccination with Immunoglobin Treatment. Pediatrics. 2013;131(4):e1135-e1143.
[No authors listed]
Pediatrics. 2014 Feb;133(2):346. doi: 10.1542/peds.2013-3728. No abstract available.
PMID: 24488301 [PubMed - in process]
Related citations
Select item 24488279 66.
Knowledge, Attitude and Practice of Hepatitis B Vaccination among Health Workers at the Lagos State Accident and Emergency Centre, Toll-Gate, Alausa, Lagos State.
Abiola AO, Omoyeni OE, Akodu BA.
West Afr J Med. 2013 Oct-Dec;32(4):257-62. English, French.
PMID: 24488279 [PubMed - in process]
Related citations
Select item 24488178 67.
Attenuated Listeria monocytogenes as a cancer vaccine vector for the delivery of CD24, a biomarker for hepatic cancer stem cells.
Yang Y, Hou J, Lin Z, Zhuo H, Chen D, Zhang X, Chen Y, Sun B.
Cell Mol Immunol. 2014 Feb 3. doi: 10.1038/cmi.2013.64. [Epub ahead of print]
PMID: 24488178 [PubMed - as supplied by publisher]
Related citations
Select item 24487961 68.
25
Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.
Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, von Boehmer L, Knuth A, Ochsenbein AF, Gnad-Vogt U, Zieschang J, Forssmann U, Woelfel T, Kaempgen E.
Cancer Immunol Immunother. 2014 Feb 2. [Epub ahead of print]
PMID: 24487961 [PubMed - as supplied by publisher]
Related citations
Select item 24486948 69.
Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure.
Mittal M, Chakravarti S, Mohapatra JK, Chug PK, Dubey R, Narwal PS, Kumar A, Churamani CP, Kanwar NS.
Infect Genet Evol. 2014 Jan 30. pii: S1567-1348(14)00018-5. doi: 10.1016/j.meegid.2014.01.015. [Epub ahead of print]
PMID: 24486948 [PubMed - as supplied by publisher]
Related citations
Select item 24486904 70.
Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp.
Nur-Nazifah M, Sabri MY, Siti-Zahrah A.
Fish Shellfish Immunol. 2014 Jan 30. pii: S1050-4648(14)00012-6. doi: 10.1016/j.fsi.2014.01.011. [Epub ahead of print]
PMID: 24486904 [PubMed - as supplied by publisher]
Related citations
Select item 24486678 71.
Journey to vaccination: a protocol for a multinational qualitative study. 26
Wheelock A, Miraldo M, Parand A, Vincent C, Sevdalis N.
BMJ Open. 2014 Jan 31;4(1):e004279. doi: 10.1136/bmjopen-2013-004279.
PMID: 24486678 [PubMed] Free PMC Article
Related citations
Select item 24486372 72.
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
Ishikawa T, Yamanaka A, Konishi E.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00074-7. doi: 10.1016/j.vaccine.2014.01.040. [Epub ahead of print]
PMID: 24486372 [PubMed - as supplied by publisher]
Related citations
Select item 24486371 73.
Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine.
Matyas GR, Rice KC, Cheng K, Li F, Antoline JF, Iyer MR, Jacobson AE, Mayorov AV, Beck Z, Torres O, Alving CR.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00060-7. doi: 10.1016/j.vaccine.2014.01.028. [Epub ahead of print]
PMID: 24486371 [PubMed - as supplied by publisher]
Related citations
Select item 24486370 74.
Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-Matched case control study.
Siriwardena AN, Asghar Z, Coupland CA.
27
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00061-9. doi: 10.1016/j.vaccine.2014.01.029. [Epub ahead of print]
PMID: 24486370 [PubMed - as supplied by publisher]
Related citations
Select item 24486369 75.
Pandemic A/H1N1 influenza vaccination during pregnancy: A comparative study using the EFEMERIS database.
Beau AB, Hurault-Delarue C, Vidal S, Guitard C, Vayssière C, Petiot D, Montastruc JL, Damase-Michel C, Lacroix I.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00053-X. doi: 10.1016/j.vaccine.2014.01.021. [Epub ahead of print]
PMID: 24486369 [PubMed - as supplied by publisher]
Related citations
Select item 24486367 76.
Hyporesponsiveness to the infecting serotype after vaccination of children with seven- valent pneumococcal conjugate vaccine following invasive pneumococcal disease.
Tamura K, Matsubara K, Ishiwada N, Nishi J, Ohnishi H, Suga S, Ihara T, Chang B, Akeda Y, Oishi K; the Japanese IPD Study Group.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00063-2. doi: 10.1016/j.vaccine.2014.01.031. [Epub ahead of print]
PMID: 24486367 [PubMed - as supplied by publisher]
Related citations
Select item 24486365 77.
CD207+ cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice.
Sol RM, Keon M, Sabrina SC, Inés BA, Silvina G, Rosa W.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00057-7. doi: 10.1016/j.vaccine.2014.01.025. [Epub ahead of print] 28
PMID: 24486365 [PubMed - as supplied by publisher]
Related citations
Select item 24486364 78.
Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR.
Pasinato A, Indolfi G, Marchisio P, Valleriani C, Cortimiglia M, Spanevello V, Chiamenti G, Buzzetti R, Resti M, Azzari C; The Italian Group for the Study of Bacterial Nasopharyngeal Carriage in Children.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00055-3. doi: 10.1016/j.vaccine.2014.01.023. [Epub ahead of print]
PMID: 24486364 [PubMed - as supplied by publisher]
Related citations
Select item 24486363 79.
Development of a Multivalent, PrPSc-Specific Prion Vaccine through Rational Optimization of Three Disease-Specific Epitopes.
Marciniuk K, Määttänen P, Taschuk R, Airey TD, Potter A, Cashman NR, Griebel P, Napper S.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00059-0. doi: 10.1016/j.vaccine.2014.01.027. [Epub ahead of print]
PMID: 24486363 [PubMed - as supplied by publisher]
Related citations
Select item 24486362 80.
Comparison of antibody and cell-mediated immune responses of foals and adult horses after vaccination with live Mycobacterium bovis BCG.
Sturgill TL, Giguère S, Berghaus LJ, Hurley DJ, Hondalus MK.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00064-4. doi: 10.1016/j.vaccine.2014.01.032. [Epub ahead of print]
PMID: 29
24486362 [PubMed - as supplied by publisher]
Related citations
Select item 24486360 81.
Overcoming the knowledge-behavior gap: The effect of evidence-based HPV caccination leaflets on understanding, intention, and actual vaccination decision.
Wegwarth O, Kurzenhäuser-Carstens S, Gigerenzer G.
Vaccine. 2014 Jan 28. pii: S0264-410X(13)01769-6. doi: 10.1016/j.vaccine.2013.12.038. [Epub ahead of print]
PMID: 24486360 [PubMed - as supplied by publisher]
Related citations
Select item 24486359 82.
The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required.
Newall AT, Dehollain JP.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00049-8. doi: 10.1016/j.vaccine.2014.01.017. [Epub ahead of print]
PMID: 24486359 [PubMed - as supplied by publisher]
Related citations
Select item 24486354 83.
Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens.
Williams JN, Weynants V, Poolman JT, Heckels JE, Christodoulides M.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00085-1. doi: 10.1016/j.vaccine.2013.12.070. [Epub ahead of print]
PMID: 24486354 [PubMed - as supplied by publisher]
30
Related citations
Select item 24486352 84.
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial.
Tinoco JC, Pavia-Ruz N, Cruz-Valdez A, Doniz CA, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK.
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00054-1. doi: 10.1016/j.vaccine.2014.01.022. [Epub ahead of print]
PMID: 24486352 [PubMed - as supplied by publisher]
Related citations
Select item 24486351 85.
Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.
Fischer Ii WA, Brighton M, Jaspers I.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00078-4. doi: 10.1016/j.vaccine.2013.12.069. [Epub ahead of print]
PMID: 24486351 [PubMed - as supplied by publisher]
Related citations
Select item 24486349 86.
Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease.
Ge J, Wang X, Tian M, Wen Z, Feng Q, Qi X, Gao H, Wang X, Bu Z.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00052-8. doi: 10.1016/j.vaccine.2014.01.020. [Epub ahead of print]
PMID: 24486349 [PubMed - as supplied by publisher]
Related citations 31
Select item 24486348 87.
Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.
Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00080-2. doi: 10.1016/j.vaccine.2013.11.106. [Epub ahead of print]
PMID: 24486348 [PubMed - as supplied by publisher]
Related citations
Select item 24486347 88.
Surface display of Clonorchis sinensis enolase on Bacillus subtilis spores potentializes an oral vaccine candidate.
Wang X, Chen W, Tian Y, Mao Q, Lv X, Shang M, Li X, Yu X, Huang Y.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00073-5. doi: 10.1016/j.vaccine.2014.01.039. [Epub ahead of print]
PMID: 24486347 [PubMed - as supplied by publisher]
Related citations
Select item 24486346 89.
Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.
De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, Landry M.
Vaccine. 2014 Jan 30. pii: S0264-410X(13)01545-4. doi: 10.1016/j.vaccine.2013.11.028. [Epub ahead of print]
PMID: 24486346 [PubMed - as supplied by publisher]
Related citations
Select item 24486345 90.
32
Neutralizing antibodies and broad, functional T cell immune response following immunization with hepatitis C virus proteins-based vaccine formulation.
Martinez-Donato G, Amador-Cañizares Y, Alvarez-Lajonchere L, Guerra I, Pérez A, Dubuisson J, Wychowsk C, Musacchio A, Aguilar D, Dueñas-Carrera S.
Vaccine. 2014 Jan 30. pii: S0264-410X(14)00083-8. doi: 10.1016/j.vaccine.2014.01.046. [Epub ahead of print]
PMID: 24486345 [PubMed - as supplied by publisher]
Related citations
Select item 24486310 91.
Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization.
Watanabe K, Matsubara A, Kawano M, Mizuno S, Okamura T, Tsujimura Y, Inada H, Nosaka T, Matsuo K, Yasutomi Y.
Vaccine. 2014 Jan 29. pii: S0264-410X(14)00087-5. doi: 10.1016/j.vaccine.2013.11.108. [Epub ahead of print]
PMID: 24486310 [PubMed - as supplied by publisher]
Related citations
Select item 24486309 92.
A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virus.
Qi X, Chen Y, Ren X, Zhang L, Gao L, Wang N, Qin L, Wang Y, Gao Y, Wang X.
Vaccine. 2014 Jan 29. pii: S0264-410X(14)00076-0. doi: 10.1016/j.vaccine.2014.01.042. [Epub ahead of print]
PMID: 24486309 [PubMed - as supplied by publisher]
Related citations
Select item 24485992 93.
Surveillance of hand, foot, and mouth disease for a vaccine. 33
Shimizu H, Nakashima K.
Lancet Infect Dis. 2014 Jan 30. pii: S1473-3099(13)70330-X. doi: 10.1016/S1473- 3099(13)70330-X. [Epub ahead of print] No abstract available.
PMID: 24485992 [PubMed - as supplied by publisher]
Related citations
Select item 24485954 94.
Influenza vaccine and false-positive HBsAg results.
Wiwanitkit V.
Transfus Apher Sci. 2014 Jan 17. pii: S1473-0502(14)00010-X. doi: 10.1016/j.transci.2014.01.008. [Epub ahead of print] No abstract available.
PMID: 24485954 [PubMed - as supplied by publisher]
Related citations
Select item 24485705 95.
Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies.
Hillen S, von Berg S, Köhler K, Reinacher M, Willems H, Reiner G.
Prev Vet Med. 2014 Jan 3. pii: S0167-5877(13)00394-2. doi: 10.1016/j.prevetmed.2013.12.012. [Epub ahead of print]
PMID: 24485705 [PubMed - as supplied by publisher]
Related citations
Select item 24485548 96.
Protection against varicella with two doses of combined measles-mumps-rubella- varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.
Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, Stefkovičova M, Usonis V, Wysocki J, Douha M, Vassilev V, Nicholson O, Innis BL, Willems P.
34
Lancet. 2014 Jan 28. pii: S0140-6736(12)61461-5. doi: 10.1016/S0140- 6736(12)61461-5. [Epub ahead of print]
PMID: 24485548 [PubMed - as supplied by publisher]
Related citations
Select item 24485547 97.
Prevention of varicella: time for two-dose vaccination.
Macartney K.
Lancet. 2014 Jan 28. pii: S0140-6736(14)60078-7. doi: 10.1016/S0140- 6736(14)60078-7. [Epub ahead of print] No abstract available.
PMID: 24485547 [PubMed - as supplied by publisher]
Related citations
Select item 24485326 98.
Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults.
Takeshita N, Lim CK, Mizuno Y, Shimbo T, Kotaki A, Ujiie M, Hayakawa K, Kato Y, Kanagawa S, Kaku M, Takasaki T.
J Infect Chemother. 2014 Jan 28. pii: S1341-321X(13)00063-9. doi: 10.1016/j.jiac.2013.11.010. [Epub ahead of print]
PMID: 24485326 [PubMed - as supplied by publisher]
Related citations
Select item 24485284 99.
Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH, Ross PJ, Allen AC, Wilk MM.
Trends Microbiol. 2014 Feb;22(2):49-52. doi: 10.1016/j.tim.2013.11.007.
PMID: 24485284
35
[PubMed - in process]
Related citations
Select item 24485154 100.
A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
Lind A, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Nilsson AL, Bomfim IL, Fink K, Lernmark A.
J Autoimmun. 2014 Jan 28. pii: S0896-8411(14)00036-5. doi: 10.1016/j.jaut.2014.01.031. [Epub ahead of print]
PMID: 24485154 [PubMed - as supplied by publisher]
Related citations
Select item 24484987 101.
New directions in nicotine vaccine design and use.
Pentel PR, Lesage MG.
Adv Pharmacol. 2014;69:553-80. doi: 10.1016/B978-0-12-420118-7.00014-7.
PMID: 24484987 [PubMed - in process]
Related citations
Select item 24484551 102.
Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients.
Gomez-Lobo V, Whyte T, Kaufman S, Torres C, Moudgil A.
Pediatr Transplant. 2014 Feb 1. doi: 10.1111/petr.12226. [Epub ahead of print]
PMID: 24484551 [PubMed - as supplied by publisher]
Related citations
36
Select item 24484500 103.
Vaccine-induced Rabies in a Red Fox (Vulpes vulpes): Isolation of Vaccine Virus in Brain Tissue and Salivary Glands.
Hostnik P, Picard-Meyer E, Rihtarič D, Toplak I, Cliquet F.
J Wildl Dis. 2014 Jan 31. [Epub ahead of print]
PMID: 24484500 [PubMed - as supplied by publisher]
Related citations
Select item 24484490 104.
SEASON AND APPLICATION RATES AFFECT VACCINE BAIT CONSUMPTION BY PRAIRIE DOGS IN COLORADO AND UTAH, USA.
Tripp DW, Rocke TE, Streich SP, Brown NL, Fernandez JR, Miller MW.
J Wildl Dis. 2014 Jan 31. [Epub ahead of print]
PMID: 24484490 [PubMed - as supplied by publisher]
Related citations
Select item 24484389 105.
Editorial: Perspective of Bacterial Vaccines -Part II.
Yang X.
Curr Pharm Biotechnol. 2014 Nov;14(11):939. No abstract available.
PMID: 24484389 [PubMed - in process]
Related citations
Select item 24484384 106.
Editorial: perspective of bacterial vaccines.
Yang X.
37
Curr Pharm Biotechnol. 2014 Nov;14(10):865-6. No abstract available.
PMID: 24484384 [PubMed - in process]
Related citations
Select item 24484292 107.
Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge.
Seo HW, Park C, Han K, Chae C.
Vet Res. 2014 Feb 2;45(1):13. [Epub ahead of print]
PMID: 24484292 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 24484238 108.
Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation.
Han K, Seo HW, Park C, Chae C.
Vet Res. 2014 Feb 2;45(1):12. [Epub ahead of print]
PMID: 24484238 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 24484116 109.
Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older.
Menzies RI, Jayasinghe SH, Krause VL, Chiu CK, McIntyre PB.
Med J Aust. 2014 Feb 3;200(2):112-5.
PMID: 24484116
38
[PubMed - in process]
Related citations
Select item 24484101 110.
A pilot study of an influenza vaccination or mask mandate in an Australian tertiary health service.
Stuart RL, Gillespie EE, Kerr PG.
Med J Aust. 2014 Feb 3;200(2):83-4. No abstract available.
PMID: 24484101 [PubMed - in process]
Related citations
Select item 24483509 111.
Behavior of susceptible-vaccinated-infected-recovered epidemics with diversity in the infection rate of individuals.
Cai CR, Wu ZX, Guan JY.
Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Dec;88(6-1):062805. Epub 2013 Dec 3.
PMID: 24483509 [PubMed - as supplied by publisher]
Related citations
Select item 24483298 112.
Correlation between Species-Specific Metabolite Profiles and Bioactivities of Blueberries (Vaccinium spp.).
Lee S, Jung ES, Do SG, Jung GY, Song G, Song JM, Lee CH.
J Agric Food Chem. 2014 Feb 2. [Epub ahead of print]
PMID: 24483298 [PubMed - as supplied by publisher]
Related citations
Select item 24483149 113.
39
Epidemiology of respiratory viral infections in children enrolled in a study of influenza vaccine effectiveness.
Dierig A, Heron LG, Lambert SB, Yin JK, Leask J, Chow MY, Sloots TP, Nissen MD, Ridda I, Booy R.
Influenza Other Respir Viruses. 2014 Jan 31. doi: 10.1111/irv.12229. [Epub ahead of print]
PMID: 24483149 [PubMed - as supplied by publisher]
Related citations
Select item 24483053 114.
[Acceptance of the vaccine against human papilloma virus from mothers to daughters aged 9 to 13 years old].
Godoy Verdugo MK, Zonana Nacach A, Anzaldo Campos MC.
Ginecol Obstet Mex. 2013 Nov;81(11):645-51. Spanish.
PMID: 24483053 [PubMed - in process]
Related citations
Select item 24482282 115.
Identification of Potential Vaccine Candidates Against Streptococcus pneumoniae by Reverse Vaccinology Approach.
Talukdar S, Zutshi S, Prashanth KS, Saikia KK, Kumar P.
Appl Biochem Biotechnol. 2014 Jan 31. [Epub ahead of print]
PMID: 24482282 [PubMed - as supplied by publisher]
Related citations
Select item 24482005 116.
Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine.
40
Murugappan S, Patil HP, Frijlink HW, Huckriede A, Hinrichs WL.
AAPS J. 2014 Jan 31. [Epub ahead of print]
PMID: 24482005 [PubMed - as supplied by publisher]
Related citations
Select item 24481894 117.
A community outreach influenza vaccination drive as a model for mass disaster prophylaxis.
Lawrenz J, Puetz J, Kuschel S, Rudzinski J.
Am J Disaster Med. 2013 Fall;8(4):287-92. doi: 10.5055/ajdm.2013.0136.
PMID: 24481894 [PubMed - in process]
Related citations
Select item 24481809 118.
It's All About the Footnotes: 2014 Vaccine Schedules.
Grogg SE.
J Am Osteopath Assoc. 2014 Feb;114(2):e76-83. doi: 10.7556/jaoa.2014.017. No abstract available.
PMID: 24481809 [PubMed - in process]
Related citations
Select item 24480625 119.
Identification of immune factors regulating anti-tumor immunity using polymeric vaccines with multiple adjuvants.
Ali OA, Verbeke C, Johnson C, Sands W, Lewin SA, White D, Doherty E, Dranoff G, Mooney DJ.
Cancer Res. 2014 Jan 30. [Epub ahead of print]
PMID:
41
24480625 [PubMed - as supplied by publisher]
Related citations
Select item 24480028 120.
Vaccines for sexually transmitted infections: Past, present and future.
Fruth U, Broutet N, Deal C, Dodet B, Meheus A.
Vaccine. 2014 Jan 27. pii: S0264-410X(14)00090-5. doi: 10.1016/j.vaccine.2014.01.051. [Epub ahead of print] No abstract available.
PMID: 24480028 [PubMed - as supplied by publisher]
Related citations
Select item 24480027 121.
The STI vaccine roadmap-A long overdue intervention.
Rees H, Holmes K.
Vaccine. 2014 Jan 27. pii: S0264-410X(14)00094-2. doi: 10.1016/j.vaccine.2014.01.055. [Epub ahead of print] No abstract available.
PMID: 24480027 [PubMed - as supplied by publisher]
Related citations
Select item 24480025 122.
Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Next Generation Herpes Simplex Virus Vaccines"
Knipe DM, Corey L, Cohen JI, Deal CD.
Vaccine. 2014 Jan 27. pii: S0264-410X(14)00091-7. doi: 10.1016/j.vaccine.2014.01.052. [Epub ahead of print] No abstract available.
PMID: 24480025 [PubMed - as supplied by publisher]
Related citations
42
Select item 24480024 123.
Vaccines against sexually transmitted infections: The way forward.
Broutet N, Fruth U, Deal C, Gottlieb SL, Rees H; participants of the 2013 STI Vaccine Technical Consultation.
Vaccine. 2014 Jan 27. pii: S0264-410X(14)00092-9. doi: 10.1016/j.vaccine.2014.01.053. [Epub ahead of print] No abstract available.
PMID: 24480024 [PubMed - as supplied by publisher]
Related citations
Select item 24479056 124.
Inadvertent Intramuscular Administration of High Dose Bacillus Calmette Guerin Vaccine in a Pre-term Infant.
Banu A, Loganathan E.
J Family Med Prim Care. 2013 Jan;2(1):95-7. doi: 10.4103/2249-4863.109967.
PMID: 24479056 [PubMed] Free PMC Article
Related citations
Select item 24478808 125.
Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines.
Chin'ombe N, Ruhanya V.
Open Virol J. 2013 Dec 30;7:121-6. doi: 10.2174/1874357901307010121. eCollection 2013.
PMID: 24478808 [PubMed] Free PMC Article
Related citations
Select item 24478777 126.
43
Designing Vaccines for the Twenty-First Century Society.
Finco O, Rappuoli R.
Front Immunol. 2014 Jan 23;5:12. eCollection 2014. Review.
PMID: 24478777 [PubMed - as supplied by publisher] Free PMC Article
Related citations
Select item 24478774 127.
AAV Vectors Vaccines Against Infectious Diseases.
Nieto K, Salvetti A.
Front Immunol. 2014 Jan 21;5:5. eCollection 2014. Review.
PMID: 24478774 [PubMed - as supplied by publisher] Free PMC Article
Related citations
Select item 24478103 128.
Vaccinated C57BL/6 Mice Develop Protective and Memory T Cell Responses to Coccidioides posadasii Infection in the Absence of Interleukin-10.
Hung CY, Castro-Lopez N, Cole GT.
Infect Immun. 2014 Feb;82(2):903-13. doi: 10.1128/IAI.01148-13. Epub 2013 Dec 9.
PMID: 24478103 [PubMed - in process]
Related citations
Select item 24478093 129.
Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in Rodents.
Teixeira LH, Tararam CA, Lasaro MO, Camacho AG, Ersching J, Leal MT, Herrera S, Bruna-Romero O, Soares IS, Nussenzweig RS, Ertl HC, Nussenzweig V, Rodrigues MM.
44
Infect Immun. 2014 Feb;82(2):793-807. doi: 10.1128/IAI.01410-13. Epub 2013 Dec 9.
PMID: 24478093 [PubMed - in process]
Related citations
Select item 24477855 130.
Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein based Mycobacterium tuberculosis based vaccines: the partial requirement for IL-17A for induction of protective immunity.
Esparza-Gonzalez SC, Troy AR, Izzo AA.
Clin Vaccine Immunol. 2014 Jan 29. [Epub ahead of print]
PMID: 24477855 [PubMed - as supplied by publisher]
Related citations
Select item 24477171 131.
Prevalence of Human Papillomavirus Types in Invasive Cervical Cancers From 7 US Cancer Registries Before Vaccine Introduction.
Hopenhayn C, Christian A, Christian WJ, Watson M, Unger ER, Lynch CF, Peters ES, Wilkinson EJ, Huang Y, Copeland G, Cozen W, Saber MS, Goodman MT, Hernandez BY, Steinau M, Lyu C, Tucker TT, Saraiya M.
J Low Genit Tract Dis. 2014 Jan 28. [Epub ahead of print]
PMID: 24477171 [PubMed - as supplied by publisher]
Related citations
Select item 24477000 132.
Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions.
Maldonado L, Teague JE, Morrow MP, Jotova I, Wu TC, Wang C, Desmarais C, Boyer JD, Tycko B, Robins HS, Clark RA, Trimble CL.
Sci Transl Med. 2014 Jan 29;6(221):221ra13. doi: 10.1126/scitranslmed.3007323.
45
PMID: 24477000 [PubMed - in process]
Related citations
Select item 24476980 133.
Notes from the field: rotavirus vaccine administration errors - United States, 2006- 2013.
Hibbs BF, Miller ER, Shimabukuro T; Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):81.
PMID: 24476980 [PubMed - in process] Free Article
Related citations
Select item 24476952 134.
Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs.
McAllister MM.
Parasitology. 2014 Jan 28:1-17. [Epub ahead of print]
PMID: 24476952 [PubMed - as supplied by publisher]
Related citations
Select item 24476932 135.
Vaccine against scabies: necessity and possibility.
Liu X, Walton S, Mounsey K.
Parasitology. 2014 Jan 28:1-8. [Epub ahead of print]
PMID: 24476932 [PubMed - as supplied by publisher]
46
Related citations
Select item 24476798 136.
Fusion of HCV non-structural antigen to MHC Class II associated invariant chain enhances T cell responses induced by vectored vaccines in non-human primates.
Capone S, Naddeo M, D'Alise AM, Abbate A, Grazioli F, Del Gaudio A, Del Sorbo M, Esposito ML, Ammendola V, Perretta G, Taglioni A, Colloca S, Nicosia A, Cortese R, Folgori A.
Mol Ther. 2014 Jan 30. doi: 10.1038/mt.2014.15. [Epub ahead of print]
PMID: 24476798 [PubMed - as supplied by publisher]
Related citations
Select item 24476680 137.
Hepatitis B vaccination for healthcare personnel in American Samoa: pre- implementation survey for policy decision.
Ly KN, Roberts H, Williams RE, Masunu-Faleafaga Y, Drobeniuc J, Kamili S, Teshale EH.
Epidemiol Infect. 2014 Jan 24:1-6. [Epub ahead of print]
PMID: 24476680 [PubMed - as supplied by publisher]
Related citations
Select item 24476428 138.
Neisseria meningitidis B vaccines: recent advances and possible immunization policies.
Gasparini R, Amicizia D, Domnich A, Lai PL, Panatto D.
Expert Rev Vaccines. 2014 Jan 29. [Epub ahead of print]
PMID: 24476428 [PubMed - as supplied by publisher]
Related citations
Select item 24476349 139.
47
Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency.
Bodemer C, Sauvage V, Mahlaoui N, Cheval J, Couderc T, Leclerc-Mercier S, Debré M, Pellier I, Gagnieur L, Fraitag S, Fischer A, Blanche S, Lecuit M, Eloit M.
Clin Microbiol Infect. 2014 Jan 30. doi: 10.1111/1469-0691.12573. [Epub ahead of print]
PMID: 24476349 [PubMed - as supplied by publisher]
Related citations
Select item 24476339 140.
Timeliness of childhood vaccine uptake among children attending a tertiary health service facility-based immunisation clinic in Ghana.
Laryea DO, Abbeyquaye Parbie E, Frimpong E.
BMC Public Health. 2014 Jan 29;14(1):90. doi: 10.1186/1471-2458-14-90.
PMID: 24476339 [PubMed - in process] Free PMC Article
Related citations
Select item 24476315 141.
Where Does a Staphylococcus aureus Vaccine Stand?
Fowler VG Jr, Proctor RA.
Clin Microbiol Infect. 2014 Jan 29. doi: 10.1111/1469-0691.12570. [Epub ahead of print]
PMID: 24476315 [PubMed - as supplied by publisher]
Related citations
Select item 24476201 142.
Role of developing countries vaccine manufacturers towards global health care by proving quality vaccines at affordable prices.
48
Jadhav S, Gautam M, Gairola S.
Clin Microbiol Infect. 2014 Jan 29. doi: 10.1111/1469-0691.12568. [Epub ahead of print]
PMID: 24476201 [PubMed - as supplied by publisher]
Related citations
Select item 24475975 143.
Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM- CSF and IL-18 can induce significant antitumor effects.
Tian H, Shi G, Yang G, Zhang J, Li Y, Du T, Wang J, Xu F, Cheng L, Zhang X, Dai L, Chen X, Zhang S, Yang Y, Yu D, Wei Y, Deng H.
BMC Cancer. 2014 Jan 29;14(1):48. [Epub ahead of print]
PMID: 24475975 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 24475552 144.
Study of adverse events following immunisation with universal and newer vaccines in the Serampore IMA Child Clinic over a period of 7 years.
Das PK.
J Indian Med Assoc. 2013 Apr;111(4):230, 232-4.
PMID: 24475552 [PubMed - in process]
Related citations
Select item 24475351 145.
Influenza Vaccines: Unmet Needs and Recent Developments.
Noh JY, Kim WJ.
Infect Chemother. 2013 Dec;45(4):375-386. Epub 2013 Dec 27. Review.
49
PMID: 24475351 [PubMed - as supplied by publisher] Free PMC Article
Related citations
Select item 24475331 146.
EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7.
Rad HS, Mousavi SL, Rasooli I, Amani J, Nadooshan MR.
Iran J Microbiol. 2013 Sep;5(3):244-51.
PMID: 24475331 [PubMed] Free PMC Article
Related citations
Select item 24475289 147.
Bacillus subtilis Spores as Vaccine Adjuvants: Further Insights into the Mechanisms of Action. de Souza RD, Batista MT, Luiz WB, Cavalcante RC, Amorim JH, Bizerra RS, Martins EG, de Souza Ferreira LC.
PLoS One. 2014 Jan 27;9(1):e87454. doi: 10.1371/journal.pone.0087454. eCollection 2014.
PMID: 24475289 [PubMed - in process] Free PMC Article
Related citations
Select item 24475246 148.
Free-riding behavior in vaccination decisions: an experimental study.
Ibuka Y, Li M, Vietri J, Chapman GB, Galvani AP.
PLoS One. 2014 Jan 24;9(1):e87164. doi: 10.1371/journal.pone.0087164. eCollection 2014.
PMID: 24475246 [PubMed - in process] 50
Free PMC Article
Related citations
Select item 24475142 149.
Randomized Controlled Ferret Study to Assess the Direct Impact of 2008-09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk.
Skowronski DM, Hamelin ME, De Serres G, Janjua NZ, Li G, Sabaiduc S, Bouhy X, Couture C, Leung A, Kobasa D, Embury-Hyatt C, de Bruin E, Balshaw R, Lavigne S, Petric M, Koopmans M, Boivin G.
PLoS One. 2014 Jan 27;9(1):e86555. doi: 10.1371/journal.pone.0086555. eCollection 2014.
PMID: 24475142 [PubMed - in process] Free PMC Article
Related citations
Select item 24474587 150.
Oncolytic Vaccinia Virus Demonstrates Anti-angiogenic Effects Mediated by Targeting of VEGF.
Hou W, Chen H, Rojas J, Sampath P, Thorne SH.
Int J Cancer. 2014 Jan 29. doi: 10.1002/ijc.28747. [Epub ahead of print]
PMID: 24474587 [PubMed - as supplied by publisher]
Related citations
Select item 24474335 151.
Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
Farsaci B, Jochems C, Grenga I, Donahue RN, Tucker JA, Pinto PA, Merino MJ, Heery CR, Madan RA, Gulley JL, Schlom J.
Int J Cancer. 2014 Jan 29. doi: 10.1002/ijc.28743. [Epub ahead of print]
PMID: 24474335 [PubMed - as supplied by publisher]
51
Related citations
Select item 24473884 152.
Calculation of the efficacy of vaccines against tick infestations on cattle.
Cunha RC, Andreotti R, Garcia MV, Aguirre Ade A, Leitão A.
Rev Bras Parasitol Vet. 2013 Oct-Dec;22(4):571-8. doi: 10.1590/S1984- 29612013000400019.
PMID: 24473884 [PubMed - in process] Free Article
Related citations
Select item 24473338 153.
Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines.
Berzi A, Varga N, Sattin S, Antonazzo P, Biasin M, Cetin I, Trabattoni D, Bernardi A, Clerici M.
Viruses. 2014 Jan 27;6(2):391-403. doi: 10.3390/v6020391.
PMID: 24473338 [PubMed - in process] Free Article
Related citations
Select item 24473272 154.
Methodology for the efficient generation of fluorescently tagged vaccinia virus proteins.
Marzook NB, Procter DJ, Lynn H, Yamamoto Y, Horsington J, Newsome TP.
J Vis Exp. 2014 Jan 17;(83). doi: 10.3791/51151.
PMID: 24473272 [PubMed - in process]
Related citations
Select item 24473104 155.
52
Development of a bio-analytical strategy for characterization of vaccine particles combining SEC and nanoES GEMMA.
Havlik M, Marchetti-Deschmann M, Friedbacher G, Messner P, Winkler W, Perez-Burgos L, Tauer C, Allmaier G.
Analyst. 2014 Jan 28. [Epub ahead of print]
PMID: 24473104 [PubMed - as supplied by publisher]
Related citations
Select item 24472456 156.
[Towards a bivalent prophylactic vaccine against hepatitis B and C viruses?].
Beaumont E, Roingeard P.
Med Sci (Paris). 2014 Jan;30(1):33-5. doi: 10.1051/medsci/20143001010. Epub 2014 Jan 24. French. No abstract available.
PMID: 24472456 [PubMed - in process]
Related citations
Select item 24472228 157.
Supplementation of oil-based inactivated H9N2 vaccine with M2e antigen enhances resistance against heterologous H9N2 avian influenza virus infection.
Park JK, Lee DH, Cho CH, Yuk SS, To EO, Kwon JH, Noh JY, Kim BY, Choi SW, Shim BS, Song MK, Lee JB, Park SY, Choi IS, Song CS.
Vet Microbiol. 2014 Jan 10. pii: S0378-1135(14)00017-0. doi: 10.1016/j.vetmic.2014.01.001. [Epub ahead of print]
PMID: 24472228 [PubMed - as supplied by publisher]
Related citations
Select item 24472196 158.
Estimated influenza illnesses and hospitalizations averted by influenza vaccination- United States, 2012-13 influenza season.
53
[No authors listed]
Am J Transplant. 2014 Feb;14(2):481-4. doi: 10.1111/ajt.12659. No abstract available.
PMID: 24472196 [PubMed - in process]
Related citations
Select item 24472154 159.
Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer.
Garland SM, Brown DR.
Expert Opin Biol Ther. 2014 Jan 28. [Epub ahead of print]
PMID: 24472154 [PubMed - as supplied by publisher]
Related citations
Select item 24471299 160.
[Screening for opportunistic infections and vaccination before introduction of biologic therapy].
Sincić BM, Vince A.
Acta Med Croatica. 2013 Apr;67(2):165-70. Croatian.
PMID: 24471299 [PubMed - in process]
Related citations
Select item 24471222 161.
Personal vaccination within COPD care.
While A.
Br J Community Nurs. 2013 Oct;18(10):520. No abstract available.
PMID: 24471222
54
[PubMed - in process]
Related citations
Select item 24482781 162.
The utility of human challenge studies in vaccine development: lessons learned from cholera.
Shirley DA, McArthur MA.
Vaccine (Auckl). 2011 Oct;2011(1):3-13.
PMID: 24482781 [PubMed] Free PMC Article
Related citations
55
AMEDEO - Vaccines Publicaciones (03 - 02 - 2014): 16 artículos nuevos.
Vacunas Neumococo (Streptococcus pneumoniae)
8. RICKETSON LJ, Wood ML, Vanderkooi OG, Macdonald JC, et al. Trends in Asymptomatic Nasopharyngeal Colonization with Streptococcus pneumoniae After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Calgary, Canada. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24463806&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24463806
Vacunas, otras
1. SIMANI OE, Izu A, Violari A, Cotton MF, et al. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014;28:531-41. PubMed: www.amedeo.com/p2.php?id=24468996&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24468996
2. TSENG HF, Schmid DS, Harpaz R, Larussa P, et al. Herpes zoster caused by vaccine strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24470276&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24470276
3. HUNG CY, Castro-Lopez N, Cole GT. Vaccinated C57BL/6 Mice Develop Protective and Memory T Cell Responses to Coccidioides posadasii Infection in the Absence of Interleukin-10. Infect Immun. 2014;82:903-13. PubMed: www.amedeo.com/p2.php?id=24478103&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24478103
4. TEIXEIRA LH, Tararam CA, Lasaro MO, Camacho AG, et al. Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in Rodents. Infect Immun. 2014;82:793-807. PubMed: www.amedeo.com/p2.php?id=24478093&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24478093
5. WRIGHT PF, Wieland-Alter W, Ilyushina NA, Hoen AG, et al. Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24459191&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24459191 56
6. HIBBS BF, Miller ER, Shimabukuro T. Notes from the field: rotavirus vaccine administration errors - United States, 2006-2013. MMWR Morb Mortal Wkly Rep. 2014;63:81. PubMed: www.amedeo.com/p2.php?id=24476980&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24476980
7. Progress toward poliomyelitis eradication - Nigeria, January 2012-September 2013. MMWR Morb Mortal Wkly Rep. 2013;62:1009-13. PubMed: www.amedeo.com/p2.php?id=24336134&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24336134
8. RICKETSON LJ, Wood ML, Vanderkooi OG, Macdonald JC, et al. Trends in Asymptomatic Nasopharyngeal Colonization with Streptococcus pneumoniae After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Calgary, Canada. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24463806&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24463806
9. WEINGARTL HM, Nfon CK, Zhang S, Marszal P, et al. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep. Vaccine. 2014 Jan 23. pii: S0264-410X(13)01815. PubMed: www.amedeo.com/p2.php?id=24462482&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24462482
10. VISALLI RJ, Natuk RJ, Kowalski J, Guo M, et al. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models. Vaccine. 2014 Jan 23. pii: S0264-410X(13)01486. PubMed: www.amedeo.com/p2.php?id=24462481&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24462481
11. OTIENO NA, Nyawanda BO, Audi A, Emukule G, et al. Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011. Vaccine. 2014 Jan 22. pii: S0264-410X(13)01498. PubMed: www.amedeo.com/p2.php?id=24462406&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24462406
12. SALAZAR MB, Dominguez JD, Estrada JS, Bonilla CG, et al. Vaccination with Leishmania mexicana LPG induces PD-1 in CD8 and PD-L2 in macrophages thereby suppressing the immune response: A model to assess vaccine efficacy.
57
Vaccine. 2014 Jan 22. pii: S0264-410X(14)00025. PubMed: www.amedeo.com/p2.php?id=24462405&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24462405
13. TANI C, Stella M, Donnarumma D, Biagini M, et al. Quantification by LC-MS of outer membrane vesicle proteins of the Bexsero vaccine. Vaccine. 2014 Jan 22. pii: S0264-410X(14)00012. PubMed: www.amedeo.com/p2.php?id=24462403&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24462403
14. BISCAYART C, Carrega ME, Sagradini S, Gentile A, et al. Yellow fever vaccine-associated adverse events following extensive immunization in Argentina. Vaccine. 2014 Jan 20. pii: S0264-410X(14)00024. PubMed: www.amedeo.com/p2.php?id=24456625&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24456625
15. O'BRIEN LM, Stokes MG, Lonsdale SG, Maslowski DR, et al. Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse. Virology. 2014 Jan 24. pii: S0042-6822(13)00181. PubMed: www.amedeo.com/p2.php?id=24461913&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24461913
16. CEPEDA V, Esteban M. Novel insights on the progression of intermediate viral forms in the morphogenesis of vaccinia virus. Virus Res. 2014 Jan 24. pii: S0168-1702(14)00030. PubMed: www.amedeo.com/p2.php?id=24468494&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24468494
58
PATENTES
United States Patent and Trademark Office (USPTO)
Estrategia de búsqueda “vaccine” en título y abstract
(ABST/vaccine AND ISD/20140129->20140207): 3 patentes recuperadas.
Vacuna Tuberculosis (Mycobacterium tuberculosis)
3 8,642,011 Tuberculosis vaccine
Vacunas cólera (Vibrio cholerae)
1 8,642,046 Cholera vaccines
Vacunas, otras
PAT. Title NO.
1 8,642,046 Cholera vaccines
2 8,642,042 Protein matrix vaccines and methods of making and
administering such vaccines
3 8,642,011 Tuberculosis vaccine
59
European Patent Office (EPO)
Acumulado entre el 29 de enero y el 7 de febrero de 2014: 24 patentes recuperadas.
Vacunas tuberculosis (Mycobacterioum tuberculosis)
21. DENDRITIC CELLS (DCS) TARGETING FOR TUBERCULOSIS (TB) VACCINE
Publication info: EP2688591 (A1) 2014-01-29
Adyuvantes
10. VACCINE ADJUVANT
US2014030296 (A1) 2014-01-30 Publication info: Vacunas, otras
1. Vaccine for alzheimer's disease
IL206998 (A) 2014-01-30 Publication info:
2. Medium for the culture of haemophilus influenzae serotype b, method for producing polyribosyl ribitol phosphate (prp) by using said medium and vaccine against haemophilus influenzae type b meningitis
IL202495 (A) 2014-01-30 Publication info:
3. Use of dengue fever vaccinal viruses for the manufacture of a monovalent vaccine and a tetravalent vaccine for immunization against dengue fever virus and immunization kits against dengue fever virus comprising said vaccines
IL198466 (A) 2014-01-30 Publication info:
4. Vaccine comprising a replikin peptide
IL195525 (A) 2014-01-30 Publication info:
5. Vaccine composition and uses thereof
IL148247 (A) 2014-01-30 Publication info:
6. METHOD AND VACCINE COMPRISING COPOLYMER 1 FOR TREATMENT OF PSYCHIATRIC DISORDERS
SI1701730 (T1) 2014-01-31 Publication info:
60
7. Inactivated dengue virus vaccine with aluminium-free adjuvant
AU2014200047 (A1) 2014-01-30 Publication info:
8. PREPARATION AND USE OF A BIVALENT VACCINE AGAINST MORPHINE- HEROINE ADDICTION
SI1767221 (T1) 2014-01-31 Publication info:
9. MODIFIED INFLUENZA VIRUS FOR MONITORING AND IMPROVING VACCINE EFFICIENCY
US2014030702 (A1) 2014-01-30 Publication info:
10. VACCINE ADJUVANT
US2014030296 (A1) 2014-01-30 Publication info:
11. VACCINE IMMUNOTHERAPY
US2014030217 (A1) 2014-01-30 Publication info:
12. MULTIMERIC FUSION PROTEIN VACCINE AND IMMUNOTHERAPEUTIC
WO2014018858 (A2) 2014-01-30 Publication info:
13. AN MVA VACCINE FOR DELIVERY OF A UL128 COMPLEX AND PREVENTING CMV INFECTION
WO2014018117 (A1) 2014-01-30 Publication info:
14. VACCINE
WO2014017493 (A1) 2014-01-30 Publication info:
15. VACCINE COMPOSITIONS FOR PREVENTION AGAINST DENGUE VIRUS INFECTION
WO2014016362 (A1) 2014-01-30 Publication info:
16. VACCINE COMPOSITIONS
WO2014016360 (A1) 2014-01-30 Publication info:
17. TUMOR ANTIGENIC PEPTIDE AND APPLICATION OF SAME AS TUMOR VACCINE
WO2014015831 (A1) 2014-01-30 Publication info:
61
18. METHOD FOR REMOVING HOST DNA FROM VACCINE
WO2014015816 (A1) 2014-01-30 Publication info:
19. Process for preparing vaccine composition
GB2504444 (A) 2014-01-29 Publication info:
20. Method for generating dry vaccine powder formulation for intranasal delivery
EP2689785 (A1) 2014-01-29 Publication info:
21. DENDRITIC CELLS (DCS) TARGETING FOR TUBERCULOSIS (TB) VACCINE
EP2688591 (A1) 2014-01-29 Publication info:
22. METHOD OF SCREENING ANTIRETROVIRAL COMPOUNDS AND VACCINE
EP2688574 (A1) 2014-01-29 Publication info:
23. METHOD FOR THE PRODUCTION OF PROTEIN COMPLEXES AND VACCINE COMPOSITIONS COMPRISING THE SAME
EP2688589 (A1) 2014-01-29 Publication info:
24. SALMONID ALPHAVIRUS VACCINE
EP2688587 (A1) 2014-01-29 Publication info:
62
TABLAS DE CONTENIDO
Revista Vaccine
New Articles in Press, 27 January-2 February 2014.
1. Refusal of oral polio vaccine in northwestern Pakistan: A qualitative and quantitative study Original Research Article
Available online 1 February 2014 Hitoshi Murakami, Makoto Kobayashi, Masahiko Hachiya, Zahir S. Khan, Syed Q. Hassan, Shinsaku Sakurada
2. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope- specific CD8+ T-cell immune responses Original Research Article
Available online 31 January 2014 Heath A. Smith, Brian T. Rekoske, Douglas G. McNeel
3. School-based vaccination of young US males: Impact of health beliefs on intent and first dose acceptance Original Research Article
Available online 31 January 2014 Vaughn I. Rickert, Beth A. Auslander, Dena S. Cox, Susan L. Rosenthal, Jeffrey A. Rickert, Richard Rupp, Gregory D. Zimet
4. Carrier priming or suppression: Understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines Review Article
Available online 31 January 2014 Karl Pobre, Mohamed Tashani, Iman Ridda, Harunor Rashid, Melanie Wong, Robert Booy
5. Corrigendum to: “Human Papillomavirus Vaccine Introduction – The First Five Years” [Vaccine 30 (Suppl. 5) (2012) F139–F148]
Available online 30 January 2014 Lauri E. Markowitz, Vivien Tsu, Shelley L. Deeks, Heather Cubie, Susan A. Wang, Andrea S. Vicari, Julia M.L. Brotherton
6. Neutralizing antibodies and broad, functional T cell immune response following immunization with hepatitis C virus proteins-based vaccine formulation Original Research Article
Available online 30 January 2014 Gillian Martinez-Donato, Yalena Amador-Cañizares, Liz Alvarez-Lajonchere, Ivis Guerra, Angel Pérez, Jean Dubuisson, Czeslaw Wychowsk, Alexis Musacchio, Daylen Aguilar, Santiago Dueñas-Carrera
63
7. Maternal pneumococcal capsular IgG antibodies and transplacental transfer are lower in South Asian HIV-infected mother-infant pairs Original Research Article
Available online 30 January 2014 Amita Gupta, Jyoti S. Mathad, Wei-Teng Yang, Harjot K. Singh, Nikhil Gupte, Vidya Mave, Renu Bharadwaj, K. Zaman, Eliza Roy, Robert C. Bollinger, Ramesh Bhosale, Mark C. Steinhoff
8. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures Original Research Article
Available online 30 January 2014 William A. Fischer II, Missy Brighton, Ilona Jaspers
9. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease Original Research Article
Available online 30 January 2014 Jinying Ge, Xijun Wang, Meijie Tian, Zhiyuan Wen, Qiulin Feng, Xiaole Qi, Honglei Gao, Xiaomei Wang, Zhigao Bu
10. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice Original Research Article
Available online 30 January 2014 Amit Kumar Singh, Joseph Kingston Jeyabalaji, Harishchandra Sripathy Murali, Harsh Vardhan Batra
11. Impact of 2 + 1 pneumococcal conjugate vaccine program in the province of Quebec, Canada Original Research Article
Available online 30 January 2014 Philippe De Wals, Brigitte Lefebvre, France Markowski, Geneviève Deceuninck, Fannie Defay, Monique Douville-Fradet, Monique Landry
12. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens Original Research Article
Available online 30 January 2014 Jeannette N. Williams, Vincent Weynants, Jan T. Poolman, John E. Heckels, Myron Christodoulides
13. Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome Original Research Article
Available online 30 January 2014 Christina D. Liakou, Varvara Askiti, Andromachi Mitsioni, Constantinos J.
64
Stefanidis, Maria C. Theodoridou, Vana I. Spoulou
14. Surface display of Clonorchis sinensis enolase on Bacillus subtilis spores potentializes an oral vaccine candidate Original Research Article
Available online 30 January 2014 Xiaoyun Wang, Wenjun Chen, Yanli Tian, Qiang Mao, Xiaoli Lv, Mei Shang, Xuerong Li, Xinbing Yu, Yan Huang
15. CD207+ cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice
Available online 29 January 2014 Ruiz María Sol, Mac Keon, Soledad Campisano Sabrina, Bravo Alicia Inés, Gazzaniga Silvina, Wainstok Rosa
16. A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virus Original Research Article
Available online 29 January 2014 Xiaole Qi, Yuming Chen, Xiangang Ren, Lizhou Zhang, Li Gao, Nian Wang, Liting Qin, Yongqiang Wang, Yulong Gao, Xiaomei Wang
17. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization Original Research Article
Available online 29 January 2014 Kenta Watanabe, Akihiro Matsubara, Mitsuo Kawano, Satoru Mizuno, Tomotaka Okamura, Yusuke Tsujimura, Hiroyasu Inada, Tetsuya Nosaka, Kazuhiro Matsuo, Yasuhiro Yasutomi
18. Evaluation of efficacy, biodistribution and safety of antibiotic-free plasmid encoding somatostatin genes delivered by attenuated Salmonella enterica serovar Choleraesuis Original Research Article
Available online 29 January 2014 Aixin Liang, Hasan Riaz, Fangxiao Dong, Xuan Luo, Xue Yu, Yanguo Han, Zhenlu Chong, Li Han, Aizhen Guo, Liguo Yang
19. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available Review Article
Available online 29 January 2014 Tomohiro Ishikawa, Atsushi Yamanaka, Eiji Konishi
20. Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease Original Research Article
Available online 29 January 2014
65
Kazuyo Tamura, Kousaku Matsubara, Naruhiko Ishiwada, Junichiro Nishi, Hidenori Ohnishi, Shigeru Suga, Toshiaki Ihara, Bin Chang, Yukihiro Akeda, Kazunori Oishi, the Japanese IPD Study Group
21. Development of a Multivalent, PrPSc-Specific Prion Vaccine through Rational Optimization of Three Disease-Specific Epitopes Original Research Article
Available online 29 January 2014 Kristen Marciniuk, Pekka Määttänen, Ryan Taschuk, T. Dean Airey, Andrew Potter, Neil R. Cashman, Philip Griebel, Scott Napper
22. Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity Original Research Article
Available online 29 January 2014 Chen-Yi Chiang, Chun-Hsiang Hsieh, Mei-Yu Chen, Jy-Ping Tsai, Hsueh-Hung Liu, Shih-Jen Liu, Pele Chong, Chih-Hsiang Leng, Hsin-Wei Chen
23. The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required
Available online 28 January 2014 Anthony T. Newall, Juan Pablo Dehollain
24. Comparison of antibody and cell-mediated immune responses of foals and adult horses after vaccination with live Mycobacterium bovis BCG Original Research Article
Available online 28 January 2014 Tracy L. Sturgill, Steeve Giguère, Londa J. Berghaus, David J. Hurley, Mary K. Hondalus
25. Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack—Matched case control study Original Research Article
Available online 28 January 2014 Aloysius N. Siriwardena, Zahid Asghar, Carol A.C. Coupland
26. Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells Original Research Article
Available online 28 January 2014 G.M. Santos-Gomes, A. Rodrigues, F. Teixeira, J. Carreira, G. Alexandre-Pires, S. Carvalho, D. Santos-Mateus, C. Martins, I. Vale-Gato, C. Marques, A.M. Tomás
Graphical abstract
27. Pandemic A/H1N1 influenza vaccination during pregnancy: A comparative study using the EFEMERIS database Original Research Article
66
Available online 28 January 2014 A.B. Beau, C. Hurault-Delarue, S. Vidal, C. Guitard, C. Vayssière, D. Petiot, J.L. Montastruc, C. Damase-Michel, I. Lacroix
28. Vaccines for sexually transmitted infections: Past, present and future
Available online 28 January 2014 Uli Fruth, Nathalie Broutet, Carolyn Deal, Betty Dodet, Andre Meheus
29. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR Original Research Article
Available online 28 January 2014 Angela Pasinato, Giuseppe Indolfi, Paola Marchisio, Claudia Valleriani, Martina Cortimiglia, Valter Spanevello, Giampietro Chiamenti, Roberto Buzzetti, Massimo Resti, Chiara Azzari, The Italian Group for the Study of Bacterial Nasopharyngeal Carriage in Children
30. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial Original Research Article
Available online 28 January 2014 Juan Carlos Tinoco, Noris Pavia-Ruz, Aurelio Cruz-Valdez, Carlos Aranza Doniz, Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Bruce L. Innis, Varsha K. Jain
31. Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on “Next Generation Herpes Simplex Virus Vaccines”
Available online 28 January 2014 David M. Knipe, Lawrence Corey, Jeffrey I. Cohen, Carolyn D. Deal
32. Preface
Available online 28 January 2014 Marleen Temmerman, Jean-Marie Okwo-Bele
33. Socioecological and message framing factors influencing maternal influenza immunization among minority women Original Research Article
Available online 28 January 2014 Paula M. Frew, Diane S. Saint-victor, Lauren E. Owens, Saad B. Omer
34. Vaccines against sexually transmitted infections: The way forward
Available online 28 January 2014 Nathalie Broutet, Uli Fruth, Carolyn Deal, Sami L. Gottlieb, Helen Rees,
67
participants of the 2013 STI Vaccine Technical Consultation
35. Overcoming the knowledge–behavior gap: The effect of evidence-based HPV caccination leaflets on understanding, intention, and actual vaccination decision Original Research Article
Available online 28 January 2014 O. Wegwarth, S. Kurzenhäuser-Carstens, G. Gigerenzer
36. Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen Original Research Article
Available online 28 January 2014 Celine A. Hayden, Emily M. Smith, Debra D. Turner, Todd K. Keener, Jeffrey C. Wong, John H. Walker, Ian R. Tizard, Rafael Jimenez-Flores, John A. Howard
37. Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6- acetylmorphine, and morphine Original Research Article
Available online 28 January 2014 Gary R. Matyas, Kenner C. Rice, Kejun Cheng, Fuying Li, Joshua F.G. Antoline, Malliga R. Iyer, Arthur E. Jacobson, Alexander V. Mayorov, Zoltan Beck, Oscar Torres, Carl R. Alving
38. The STI vaccine roadmap—A long overdue intervention
Available online 28 January 2014 Helen Rees, King Holmes
39. Declarations of interest
Available online 28 January 2014
68